GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and ...
In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of ...
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...
GLP-1 drugs have come to be thought of as “wonder drugs,” yet the mechanisms behind their many new health benefits have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results